IMMUNIC, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1200 AVENUE OF THE AMERICAS, NEW YORK, X1, 10036
Mailing Address 1200 AVENUE OF THE AMERICAS, NEW YORK, X1, 10036
Phone (332) 255-9818
Fiscal Year End 1231
EIN 562358443
Financial Overview
FY2024
$54.30M
Total Assets
$46.67M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 2, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 8-K Current report of material events | January 5, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 8, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 14, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
Material Events
8-K Financial Distress January 6, 2026
High Impact
- IMMUNIC, INC. is moving its stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market due to its stock price falling below the $1.00 minimum bid price requirement.
- This transfer grants the company an additional 180 days, until June 22, 2026, to regain compliance with Nasdaq's minimum bid price rule.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.